QSAM Biosciences Closes Series B Preferred Private Placement led by Checkmate Capital.
Austin, Texas, Jan. 28, 2021 (GLOBE NEWSWIRE) -- QSAM Biosciences Inc. (OTCQB: QSAM), a company developing next-generation nuclear...
QSAM Biosciences Closes Series B Preferred Private Placement led by Checkmate Capital.
Checkmate Capital Group Completes Seed Investment in Lactiga, Inc.
NeuroSigma Receives Bridge Financing from Checkmate Capital
Monarch Biosciences Closes Seed Round Financing